Title: Coletti A, et al. Fragment-based approach to identify IDO1 inhibitor building blocks. Eur J Med Chem. 2017 Dec 1;141:169-177.
1402837-78-8
1402836-76-3
1402836-86-5
1402838-89-4
140645-53-0 | 2-Aminomethyl-4-Boc-morpholine | AA001CKJ | MFCD06410633
1408075-99-9 | Trans-3-fluorocyclobutanamine hydrochloride | AA001CS3 | MFCD23106125
14559-14-9 | Diethyl 3-methylthiophene-2,4-dicarboxylate | AA001D4W | MFCD02257711
145934-89-0 | 2-Chloro-5-hydrazinylpyridine | AA001DGG | MFCD16251142
1462-39-1 | 3-(2-Chloroethoxy)prop-1-ene | AA001DQA | MFCD06411074
146514-35-4 | tert-Butyl (2-oxotetrahydrofuran-3-yl)carbamate | AA001E0U | MFCD00799499
146939-27-7 | 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one | AA001ED1 | MFCD00866661
147194-40-9 | 4-((2-Hydroxyethyl)amino)-1,2,5-oxadiazole-3-carboxylic acid | AA001ELW | MFCD00984735
147619-40-7 | 5-Chloro-1,2-dihydro-4-methoxy-2-oxo-3-pyridinecarbonitrile | AA001EY6 | MFCD07368155
14790-42-2 | 4-Chloro-2-phenylpyrimidine | AA001F7I | MFCD00234601